Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PRLB - Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2022


PRLB - Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2022

Revenue of $115.6 million in the Fourth Quarter of 2022
Record Annual Revenue of $488.4 million in 2022
Increases share repurchase authorization to $250 million

Proto Labs, Inc. (the "Company" or "Protolabs") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter 2022 Highlights include :

  • Revenue for the fourth quarter of 2022 was $115.6 million, representing a 6.5 percent decrease compared to revenue of $123.6 million in the fourth quarter of 2021.
  • Revenue generated from our digital network powered by Hubs was $14.8 million in the fourth quarter, representing growth of 49.6 percent over the fourth quarter of 2021 and 22.2 percent sequential growth compared to the third quarter of 2022.
  • Net loss for the fourth quarter of 2022 was $115.1 million, or ($4.24) per diluted share, driven by a goodwill impairment charge of $118.0 million.
  • Non-GAAP net income was $7.0 million, or $0.26 per diluted share. See “Non-GAAP Financial Measures” below.

Expanded Share Repurchase Program :

  • On February 7, 2023, Protolabs' Board of Directors approved $50 million increase to existing Share Repurchase Program, bringing the total amount authorized under the program to $250 million.
  • As of December 31, 2022, the Company has purchased $117.7 million under the program, which expires December 31, 2024.
  • With the increased authorization, the Company has $132.3 million remaining to repurchase shares under the expanded program.

“In a challenging economic environment, impacted by inflation, slowing growth and continued supply chain challenges, our Protolabs and Hubs teams continued to delight our customers as together we build the most comprehensive digital manufacturing capabilities in the world,” said Rob Bodor, President and Chief Executive Officer. “Following the launch of several new offers in 2022 and early 2023, we are well-positioned to extend our market differentiation with quality internal manufacturing at speed and the expansive breadth and depth afforded by our curated network of manufacturing partners.”

Full Year 2022 Highlights include :

  • Record annual revenue of $488.4 million in 2022.
  • Protolabs served 56,333 unique product developers during the year.
  • Gross margin was 44.1 percent of revenue in 2022, compared to 45.6 percent in 2021.
  • EBITDA margin was (12.2 percent) of revenue in 2022 driven by a fourth quarter goodwill impairment charge of $118.0 million, compared to 16.5 percent in 2021.
  • Adjusted EBITDA margin was 17.1 percent of revenue in 2022, compared to 18.3 percent in 2021. See “Non-GAAP Financial Measures” below.
  • Net loss for 2022 was $103.5 million, or ($3.77) per diluted share.
  • Non-GAAP net income was $41.1 million, or $1.50 per diluted share. See “Non-GAAP Financial Measures” below.
  • Cash and investments balance was $106.5 million as of December 31, 2022.

“As we narrow our focus in 2023 on growth of our Injection Molding business and accelerating growth from the integrated Protolabs and Hubs CNC offer, we are managing expenses to enable continued strategic investments which we expect to drive profitable revenue growth,” said Dan Schumacher, Chief Financial Officer. “Combined with a healthy financial position and strong cash balance, disciplined cost management will help fuel growth of the business while returning capital to our shareholders.”

Expanded Share Repurchase Program

Under the expanded $250 million Share Repurchase Program, shares of the Company’s common stock may be repurchased periodically, including in the open market or privately negotiated transactions. The actual timing, manner, number, and value of shares repurchased under the program will be determined by management at its discretion and will depend on several factors, including the market price of Proto Labs’ common stock, general market and economic conditions, applicable requirements, and other business considerations. The Share Repurchase Program does not obligate the Company to acquire any particular amount of shares of the Company’s stock.

Non-GAAP Financial Measures

The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates and revenue earned from our acquisition of Hubs (collectively, “non-GAAP revenue growth”). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the Company.

The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for goodwill impairment charges, stock-based compensation expense, unrealized (gain) loss on foreign currency, costs related to the Japan closure activities and transaction costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for goodwill impairment charges, stock-based compensation expense, unrealized (gain) loss on foreign currency, costs related to the Japan closure activities and transaction costs (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP operating margin, adjusted for goodwill impairment charges, stock-based compensation expense, amortization expense, costs related to the closure of Japan, and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP gross margin excluding Japan, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results. The Company has included non-GAAP operating margin excluding Japan, adjusted for goodwill impairment charges, stock-based compensation expense, amortization expense, costs related to the Japan closure activities and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP net income, adjusted for goodwill impairment charges, stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, costs related to the closure of Japan, and transaction costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP gross margin, non-GAAP gross margin excluding Japan, non-GAAP operating margin, non-GAAP operating margin excluding Japan, non-GAAP revenue growth by region and by service, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the Company’s business. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

Conference Call

The Company has scheduled a conference call to discuss its fourth quarter and full year 2022 financial results and first quarter 2023 outlook today, February 10, 2023 at 8:30 a.m. EST. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EST start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/d3nzbm3z . A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

About Protolabs

Protolabs is the fastest and most comprehensive digital manufacturing service in the world. Our digital factories produce low-volume parts in days while our supply network powered by Hubs unlocks advanced capabilities and volume pricing at higher quantities. The result? One manufacturing source—from prototyping to production—for product developers, engineers, and supply chain teams across the globe. See what's next at protolabs.com .

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the Securities and Exchange Commission. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

Proto Labs, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

December 31,

December 31,

2022

2021

(Unaudited)

Assets

Current assets

Cash and cash equivalents

$

56,558

$

65,929

Short-term marketable securities

23,568

11,580

Accounts receivable, net

76,225

80,051

Inventory

13,578

13,161

Income taxes receivable

4,042

1,321

Prepaid expenses and other current assets

12,597

11,450

Total current assets

186,568

183,492

Property and equipment, net

257,785

280,346

Goodwill

273,991

400,610

Other intangible assets, net

31,250

37,998

Long-term marketable securities

26,419

14,340

Operating lease assets

3,844

5,578

Finance lease assets

17,532

1,898

Other long-term assets

4,779

4,320

Total assets

$

802,168

$

928,582

Liabilities and shareholders' equity

Current liabilities

Accounts payable

$

17,356

$

25,364

Accrued compensation

12,743

13,704

Accrued liabilities and other

22,384

11,980

Current operating lease liabilities

1,561

3,298

Current finance lease liabilities

17,537

550

Total current liabilities

71,581

54,896

Long-term operating lease liabilities

2,255

2,245

Long-term finance lease liabilities

-

1,351

Long-term deferred tax liabilities

26,322

35,892

Other long-term liabilities

4,362

5,705

Shareholders' equity

697,648

828,493

Total liabilities and shareholders' equity

$

802,168

$

928,582

Proto Labs, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share amounts)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

Injection Molding

$

44,885

$

53,905

$

200,578

$

226,117

CNC Machining

46,563

44,858

188,372

166,811

3D Printing

19,530

18,727

78,988

72,721

Sheet Metal

4,432

5,607

19,498

20,397

Other

197

485

962

2,052

Total revenue

115,607

123,582

488,398

488,098

Cost of revenue

67,000

68,170

272,933

265,407

Gross profit

48,607

55,412

215,465

222,691

Operating expenses

Marketing and sales

20,517

20,229

82,752

82,175

Research and development

8,906

10,386

38,222

44,241

General and administrative

17,774

11,747

67,544

55,933

Goodwill impairment

118,008

-

118,008

-

Closure of Japan business

534

-

6,922

-

Total operating expenses

165,739

42,362

313,448

182,349

(Loss) income from operations

(117,132

)

13,050

(97,983

)

40,342

Other income (expense), net

429

(118

)

106

(158

)

(Loss) income before income taxes

(116,703

)

12,932

(97,877

)

40,184

Provision for income taxes

(1,638

)

1,022

5,585

6,812

Net (loss) income

$

(115,065

)

$

11,910

$

(103,462

)

$

33,372

Net (loss) income per share:

Basic

$

(4.24

)

$

0.43

$

(3.77

)

$

1.21

Diluted

$

(4.24

)

$

0.43

$

(3.77

)

$

1.21

Shares used to compute net (loss) income per share:

Basic

27,136,821

27,555,357

27,409,838

27,617,627

Diluted

27,136,821

27,562,694

27,409,838

27,653,099

Proto Labs, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Year Ended

December 31,

2022

2021

Operating activities

Net (loss) income

$

(103,462

)

$

33,372

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

39,425

40,488

Stock-based compensation expense

17,545

19,095

Deferred taxes

(9,499

)

339

Changes in fair value of contingent consideration

-

(13,253

)

Loss on impairment of goodwill

118,008

-

Impairments related to closure of Japan business

2,842

-

Gain on disposal of property and equipment

(1,211

)

-

Other

35

842

Changes in operating assets and liabilities

(1,604

)

(25,641

)

Net cash provided by operating activities

62,079

55,242

Investing activities

Purchases of property, equipment and other capital assets

(21,686

)

(34,209

)

Proceeds from sales of property, equipment and other capital assets

4,108

-

Cash used for acquisitions, net of cash acquired

-

(127,413

)

Purchases of marketable securities

(46,872

)

(16,159

)

Proceeds from sales of marketable securities

1,998

64,913

Proceeds from call redemptions and maturities of marketable securities

19,360

18,204

Net cash used in investing activities

(43,092

)

(94,664

)

Financing activities

Proceeds from exercises of stock options and other

3,950

5,862

Purchases of shares withheld for tax obligations

(1,682

)

(4,225

)

Repurchases of common stock

(29,659

)

(23,279

)

Principal repayments of finance lease obligations

(531

)

(552

)

Other

-

(4

)

Net cash used in financing activities

(27,922

)

(22,198

)

Effect of exchange rate changes on cash and cash equivalents

(436

)

(54

)

Net decrease in cash and cash equivalents

(9,371

)

(61,674

)

Cash and cash equivalents, beginning of period

65,929

127,603

Cash and cash equivalents, end of period

$

56,558

$

65,929

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Net Income per Share

(In thousands, except share and per share amounts)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Non-GAAP net (loss) income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, goodwill impairment, costs related to Japan closure activities and transaction costs

GAAP net (loss) income

$

(115,065

)

$

11,910

$

(103,462

)

$

33,372

Add back:

Stock-based compensation expense

4,210

3,556

17,545

19,095

Amortization expense

1,514

1,552

6,096

6,153

Unrealized (gain) loss on foreign currency

(490

)

215

252

556

Goodwill impairment

118,008

-

118,008

-

Costs related to Japan closure activities

534

-

6,922

-

Transaction costs 1

-

(4,705

)

-

(10,575

)

Total adjustments 2

123,776

618

148,823

15,229

Income tax benefits on adjustments 3

(1,753

)

(1,150

)

(4,271

)

(5,789

)

Non-GAAP net income

$

6,958

$

11,378

$

41,090

$

42,812

Non-GAAP net income per share:

Basic

$

0.26

$

0.41

$

1.50

$

1.55

Diluted

$

0.26

$

0.41

$

1.50

$

1.55

Shares used to compute non-GAAP net income per share:

Basic

27,136,821

27,555,357

27,409,838

27,617,627

Diluted

27,151,991

27,562,694

27,433,257

27,653,099

1

Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

2

Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, goodwill impairment, costs related to Japan closure activities and transaction costs were included in the following GAAP consolidated statement of operations categories:

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Cost of revenue

$

840

$

990

$

3,541

$

3,964

Marketing and sales

816

895

3,295

3,736

Research and development

488

689

2,190

2,833

General and administrative

3,580

(2,171

)

14,615

4,140

Goodwill impairment

118,008

-

118,008

-

Closure of Japan business

534

-

6,922

-

Total operating expenses

123,426

(587

)

145,030

10,709

Other (income) expense, net

(490

)

215

252

556

Total adjustments

$

123,776

$

618

$

148,823

$

15,229

3

For the three-month and year-ended periods ended December 31, 2022 and 2021, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin

(In thousands)

(Unaudited)

Three Months Ended

Year Ended

Three Months Ended

December 31,

December 31,

September 30,

2022

2021

2022

2021

2022

2021

Revenue

$

115,607

$

123,582

$

488,398

$

488,098

$

121,721

$

125,342

Gross Profit

48,607

55,412

215,465

222,691

53,632

55,324

GAAP gross margin

42.0

%

44.8

%

44.1

%

45.6

%

44.1

%

44.1

%

Add back:

Stock-based compensation expense

498

648

2,172

2,595

560

644

Amortization expense

342

342

1,369

1,369

342

342

Total adjustments

840

990

3,541

3,964

902

986

Non-GAAP gross profit

$

49,447

$

56,402

$

219,006

$

226,655

$

54,534

$

56,310

Non-GAAP gross margin

42.8

%

45.6

%

44.8

%

46.4

%

44.8

%

44.9

%

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin Excluding Japan

(In thousands)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

$

115,607

$

123,582

$

488,398

$

488,098

Revenue excluding Japan

$

115,607

$

120,074

$

480,169

$

474,857

Gross Profit

48,607

55,412

215,465

222,691

GAAP gross margin

42.0

%

44.8

%

44.1

%

45.6

%

Less: Japan gross (loss) profit

(93

)

1,568

3,057

5,413

Gross Profit excluding Japan

48,700

53,844

212,408

217,278

GAAP gross margin excluding Japan

42.1

%

44.8

%

44.2

%

45.8

%

Add back:

Stock-based compensation expense

498

648

2,172

2,595

Amortization expense

342

342

1,369

1,369

Less:

Japan stock-based compensation expense

-

26

61

96

Japan amortization expense

-

-

-

-

Total adjustments

840

964

3,480

3,868

Non-GAAP gross profit excluding Japan

$

49,540

$

54,808

$

215,888

$

221,146

Non-GAAP gross margin excluding Japan

42.9

%

45.6

%

45.0

%

46.6

%

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin

(In thousands)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

$

115,607

$

123,582

$

488,398

$

488,098

(Loss) income from operations

(117,132

)

13,050

(97,983

)

40,342

GAAP operating margin

(101.3

)%

10.6

%

(20.1

)%

8.3

%

Add back:

Stock-based compensation expense

4,210

3,556

17,545

19,095

Amortization expense

1,514

1,552

6,096

6,153

Transaction costs 1

-

(4,705

)

-

(10,575

)

Goodwill impairment

118,008

-

118,008

-

Costs related to Japan closure activities

534

-

6,922

-

Total adjustments

124,266

403

148,571

14,673

Non-GAAP income from operations

$

7,134

$

13,453

$

50,588

$

55,015

Non-GAAP operating margin

6.2

%

10.9

%

10.4

%

11.3

%

1

Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin Excluding Japan

(In thousands)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

$

115,607

$

123,582

$

488,398

$

488,098

Revenue excluding Japan

$

115,607

$

120,074

$

480,169

$

474,857

(Loss) income from operations

(117,132

)

13,050

(97,983

)

40,342

GAAP operating margin

(101.3

)%

10.6

%

(20.1

)%

8.3

%

Less: Japan (loss) income from operations

(594

)

154

(1,424

)

(1,020

)

(Loss) income from operations excluding Japan

(116,538

)

12,896

(96,559

)

41,362

GAAP operating margin excluding Japan

(100.8

)%

10.7

%

(20.1

)%

8.7

%

Add back:

Stock-based compensation expense

4,210

3,556

17,545

19,095

Amortization expense

1,514

1,552

6,096

6,153

Transaction costs 1

-

(4,705

)

-

(10,575

)

Goodwill impairment

118,008

-

118,008

-

Costs related to Japan closure activities

534

-

6,922

-

Less:

Japan stock-based compensation expense

20

163

406

626

Japan amortization expense

-

-

-

-

Total adjustments

124,246

240

148,165

14,047

Non-GAAP income from operations excluding Japan

$

7,708

$

13,136

$

51,606

$

55,409

Non-GAAP operating margin excluding Japan

6.7

%

10.9

%

10.7

%

11.7

%

1

Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

Proto Labs, Inc.

Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA

(In thousands)

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

$

115,607

$

123,582

$

488,398

$

488,098

GAAP net (loss) income

(115,065

)

11,910

(103,462

)

33,372

GAAP net (loss) income margin

(99.5

)%

9.6

%

(21.2

)%

6.8

%

Add back:

Amortization expense

$

1,514

$

1,552

$

6,096

$

6,153

Depreciation expense

7,930

8,705

33,329

34,335

Interest income, net

(509

)

(23

)

(968

)

(230

)

Tax expense

(1,638

)

1,022

5,585

6,812

EBITDA

(107,768

)

23,166

(59,420

)

80,442

EBITDA Margin

(93.2

)%

18.7

%

(12.2

)%

16.5

%

Add back:

Stock-based compensation expense

4,210

3,556

17,545

19,095

Unrealized (gain) loss on foreign currency

(490

)

215

252

556

Costs related to Japan closure activities

534

-

6,922

-

Goodwill impairment

118,008

-

118,008

-

Transaction costs 1

-

(4,705

)

-

(10,575

)

Total adjustments

122,262

(934

)

142,727

9,076

Adjusted EBITDA

$

14,494

$

22,232

$

83,307

$

89,518

Adjusted EBITDA Margin

12.5

%

18.0

%

17.1

%

18.3

%

1

Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Region

(In thousands)

(Unaudited)

Three Months Ended
December 31, 2022

Three Months Ended
December 31, 2021

GAAP

Foreign
Currency1

Hubs
Acquisition

Non-GAAP

GAAP

%
Change3

%
Change
Organic4

Revenues

United States

$

92,278

$

-

$

-

$

92,278

$

97,934

(5.8)

%

(5.8

)%

Europe

23,329

3,216

-

26,545

22,140

5.4

19.9

Japan

-

-

-

-

3,508

(100.0

)

(100.0

)

Total Revenue

$

115,607

$

3,216

$

-

$

118,823

$

123,582

(6.5

)%

(3.9

)%

Year Ended
December 31, 2022

Year Ended
December 31, 2021

GAAP

Foreign
Currency1

Hubs
Acquisition2

Non-GAAP

GAAP

%
Change3

%
Change
Organic4

Revenues

United States

$

387,399

$

-

$

(1,049

)

$

386,350

$

384,458

0.8

%

0.5

%

Europe

92,770

10,381

(1,279

)

101,872

90,399

2.6

12.7

Japan

8,229

1,226

-

9,455

13,241

(37.9

)

(28.6

)

Total Revenue

$

488,398

$

11,607

$

(2,328

)

$

497,677

$

488,098

0.1

%

2.0

%

1 Revenue for the three-month and year-ended periods ended December 31, 2022 has been recalculated using 2021 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

2 Revenue for the year-ended period ended December 31, 2022 has been recalculated to exclude revenue earned from the Company's acquisition of Hubs, Inc. for the period from January 1, 2022 to January 21, 2022 to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions. The Hubs, Inc. acquisition occurred on January 22, 2021 and was included in 2021 revenue after that date.

3 This column presents the percentage change from GAAP revenue for the three-month and year-ended periods ended December 31, 2021 to GAAP revenue for the three-month and year-ended periods ended December 31, 2022.

4 This column presents the percentage change from GAAP revenue for the three-month and year-ended periods ended December 31, 2021 to non-GAAP revenue for the three-month and year-ended periods ended December 31, 2022 (as recalculated using the foreign currency exchange rates in effect during the three-month and year-ended periods ended December 31, 2021, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Service Line

(In thousands)

(Unaudited)

Three Months Ended
December 31, 2022

Three Months Ended
December 31, 2021

GAAP

Foreign
Currency1

Hubs
Acquisition

Non-GAAP

GAAP

%
Change3

%
Change
Organic4

Revenues

Injection Molding

$

44,885

$

1,383

$

-

$

46,268

$

53,905

(16.7

)%

(14.2

)%

CNC Machining

46,563

1,083

-

47,646

44,858

3.8

6.2

3D Printing

19,530

726

-

20,256

18,727

4.3

8.2

Sheet Metal

4,432

24

-

4,456

5,607

(21.0

)

(20.5

)

Other

197

-

-

197

485

(59.4

)

(59.4

)

Total Revenue

$

115,607

$

3,216

$

-

$

118,823

$

123,582

(6.5

)%

(3.9

)%

Year Ended
December 31, 2022

Year Ended
December 31, 2021

GAAP

Foreign
Currency1

Hubs
Acquisition2

Non-GAAP

GAAP

%
Change3

%
Change
Organic4

Revenues

Injection Molding

$

200,578

$

5,485

$

(189

)

$

205,874

$

226,117

(11.3

)%

(9.0

)%

CNC Machining

188,372

3,776

(1,637

)

190,511

166,811

12.9

14.2

3D Printing

78,988

2,279

(408

)

80,859

72,721

8.6

11.2

Sheet Metal

19,498

63

(84

)

19,477

20,397

(4.4

)

(4.5

)

Other

962

4

(10

)

956

2,052

(53.1

)

(53.4

)

Total Revenue

$

488,398

$

11,607

$

(2,328

)

$

497,677

$

488,098

0.1

%

2.0

%

1 Revenue for the three-month and year-ended periods ended December 31, 2022 has been recalculated using 2021 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

2 Revenue for the year-ended period ended December 31, 2022 has been recalculated to exclude revenue earned from the Company's acquisition of Hubs, Inc. for the period from January 1, 2022 to January 21, 2022 to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions. The Hubs, Inc. acquisition occurred on January 22, 2021 and was included in 2021 revenue after that date.

3 This column presents the percentage change from GAAP revenue for the three-month and year-ended periods ended December 31, 2021 to GAAP revenue for the three-month and year-ended periods ended December 31, 2022.

4 This column presents the percentage change from GAAP revenue for the three-month and year-ended periods ended December 31, 2021 to non-GAAP revenue for the three-month and year-ended periods ended December 31, 2022 (as recalculated using the foreign currency exchange rates in effect during the three-month and year-ended periods ended December 31, 2021, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.

Proto Labs, Inc.

Product Developer Information

(Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Unique product developers and engineers served

22,205

23,376

56,333

55,330

View source version on businesswire.com: https://www.businesswire.com/news/home/20230210005085/en/

Investor Relations Contact
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and FP&A
ryan.johnsrud@protolabs.com

Media Contact
Protolabs
Brent Renneke, 763-479-7704
PR & Media Strategist
brent.renneke@protolabs.com

Stock Information

Company Name: Proto Labs Inc.
Stock Symbol: PRLB
Market: NYSE
Website: protolabs.com

Menu

PRLB PRLB Quote PRLB Short PRLB News PRLB Articles PRLB Message Board
Get PRLB Alerts

News, Short Squeeze, Breakout and More Instantly...